πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 423 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7419600

Method for purifying a branched water-soluble polymer

Nektar Therapeutics AL, Corporation Β· Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7405266

Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof

Nektar Therapeutics AL, Corporation Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7393544

Dispersion for pulmonary delivery of a bioactive agent

Nektar Therapeutics Β· Granted Tue Jul 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378469

Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

Nektar Therapeutics AL, Corporation Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7368102

Pulmonary delivery of aminoglycosides

Nektar Therapeutics Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7329721

Maleamic acid polymer derivatives and their bioconjugates

Nektar Therapeutics AL, Corporation Β· Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7326691

Compositions comprising amphotericin B, methods, and systems

Nektar Therapeutics Β· Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7316811

Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehicles

Nektar Therapeutics AL, Corporation Β· Granted Tue Jan 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7312301

Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

Nektar Therapeutics AL, Corporation Β· Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7306787

Engineered particles and methods of use

Nektar Therapeutics Β· Granted Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7300919

Pulmonary delivery of active fragments of parathyroid hormone

Nektar Therapeutics Β· Granted Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7265186

Multi-arm block copolymers as drug delivery vehicles

Nektar Therapeutics AL, Corporation Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7223803

Polyethylene (glycol) derivatives with proximal reactive groups

Nektar Therapeutics AL, Corporation Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7214366

Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glyc

Nektar Therapeutics AL, Corporation Β· Granted Tue May 08 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7208145

Polymeric reagents comprising a ketone or a related functional group

Nektar Therapeutics AL, Corporation Β· Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7205380

Sterically hindered poly (ethylene glycol) alkanoic acids and derivatives thereof

Nektar Therapeutics AL, Corporation Β· Granted Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7199223

Polymer-factor VIII moiety conjugates

Nektar Therapeutics AL, Corporation Β· Granted Tue Apr 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7172768

Storage stable powder compositions of interleukin-4 receptor

Nektar Therapeutics Β· Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7157546

Water-soluble polymer alkanals

Nektar Therapeutics AL, Corporation Β· Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7150766

Method of particle formation

Nektar Therapeutics UK, Ltd Β· Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7141236

Methods and compositions for delivering macromolecules to or via the respiratory tract

Nektar Therapeutics Β· Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7138141

Dispersible macromolecule compositions and methods for their preparation and use

Nektar Therapeutics Β· Granted Tue Nov 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7115280

Particle formation methods and their products

Nektar Therapeutics UK, Ltd Β· Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7112341

Pulmonary administration of dry powder formulations for treating infertility

Nektar Therapeutics Β· Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted